Relay Therapeutics Inc.

09/12/2024 | Press release | Distributed by Public on 09/12/2024 21:05

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium